| Product Code: ETC7656938 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuro invasive Infection Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuro invasive Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuro invasive Infection Market - Industry Life Cycle |
3.4 Israel Neuro invasive Infection Market - Porter's Five Forces |
3.5 Israel Neuro invasive Infection Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Neuro invasive Infection Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Neuro invasive Infection Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 Israel Neuro invasive Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuro invasive infections in Israel |
4.2.2 Growing awareness and diagnosis of neuro invasive infections |
4.2.3 Advancements in medical technology for diagnosing and treating neuro invasive infections |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for neuro invasive infection treatment |
4.3.2 High treatment costs associated with neuro invasive infections |
4.3.3 Stringent regulatory requirements for neuro invasive infection treatment products |
5 Israel Neuro invasive Infection Market Trends |
6 Israel Neuro invasive Infection Market, By Types |
6.1 Israel Neuro invasive Infection Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuro invasive Infection Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Neuro invasive Infection Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.1.4 Israel Neuro invasive Infection Market Revenues & Volume, By Encephalitis, 2021- 2031F |
6.1.5 Israel Neuro invasive Infection Market Revenues & Volume, By Acute Flaccid Paralysis, 2021- 2031F |
6.2 Israel Neuro invasive Infection Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuro invasive Infection Market Revenues & Volume, By Four-fold Virus-specific Serum Antibody Titer, 2021- 2031F |
6.2.3 Israel Neuro invasive Infection Market Revenues & Volume, By Enzyme Immunoassay (EIA), 2021- 2031F |
6.2.4 Israel Neuro invasive Infection Market Revenues & Volume, By Antibody-capture Enzyme Immunoassay (EIA), 2021- 2031F |
6.3 Israel Neuro invasive Infection Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Neuro invasive Infection Market Revenues & Volume, By Antiviral Agents, 2021- 2031F |
6.3.3 Israel Neuro invasive Infection Market Revenues & Volume, By Steroid Injection, 2021- 2031F |
6.3.4 Israel Neuro invasive Infection Market Revenues & Volume, By Immunoglobulin Therapy, 2021- 2031F |
6.3.5 Israel Neuro invasive Infection Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.3.6 Israel Neuro invasive Infection Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neuro invasive Infection Market Import-Export Trade Statistics |
7.1 Israel Neuro invasive Infection Market Export to Major Countries |
7.2 Israel Neuro invasive Infection Market Imports from Major Countries |
8 Israel Neuro invasive Infection Market Key Performance Indicators |
8.1 Number of reported cases of neuro invasive infections in Israel |
8.2 Adoption rate of advanced diagnostic technologies for neuro invasive infections |
8.3 Research and development investments in new treatments for neuro invasive infections |
9 Israel Neuro invasive Infection Market - Opportunity Assessment |
9.1 Israel Neuro invasive Infection Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Neuro invasive Infection Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Neuro invasive Infection Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 Israel Neuro invasive Infection Market - Competitive Landscape |
10.1 Israel Neuro invasive Infection Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuro invasive Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here